◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › EMCURE › EPS

Emcure Pharmaceuticals Limited (EMCURE) EPS 2022–2026

DATA UPDATED 2026-09-20

Emcure Pharmaceuticals Limited annual earnings per share (EPS) for fiscal 2026 was ₹48.77, an increase of 33.9% from ₹36.43 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

EMCURE Annual EPS

EPS (annual)2026-03-312025-03-312024-03-312023-03-312022-03-31
Diluted EPS₹49M₹36M₹28M₹29M—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMCURE Quarterly EPS

EPS (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Diluted EPS₹16M₹13M₹12M₹13M₹11M——

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EPS at Comparable Companies

More EMCURE metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow

All EMCURE financial statements → Interactive EMCURE charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.